Regulatory Fate of Cancer Indications in the European Union After Accelerated Approval in the US.
Sign Up to like & getrecommendations! Published in 2024 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2024.5145
Abstract: This cohort study investigates the regulatory fate in the European Union for drugs that received accelerated approval for cancer indications in the US. read more here.
Keywords: cancer indications; regulatory fate; european union; accelerated approval ... See more keywords
Antibodies to watch in 2018
Sign Up to like & getrecommendations! Published in 2018 at "mAbs"
DOI: 10.1080/19420862.2018.1415671
Abstract: ABSTRACT The pace of antibody therapeutics development accelerated in 2017, and this faster pace is projected to continue through 2018. Notably, the annual number of antibody therapeutics granted a first approval in either the European… read more here.
Keywords: cancer indications; antibody therapeutics; antibodies watch; watch 2018 ... See more keywords
Abstract 4146: Unlocking IO drug potential by high content imaging of immune cell co-cultures with cancer organoids from diverse cancer indications
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-4146
Abstract: Introduction Immuno-oncology (IO) drugs have shown great results for specific cancer indications in the clinic, most notably for hematological cancers, as well as some solid cancers such as melanoma. However, the potential of many IO… read more here.
Keywords: cell; cancer indications; immune cell; high content ... See more keywords